Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHYLENE BLUE vs METOCLOPRAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

METHYLENE BLUE vs METOCLOPRAMIDE: Safety Overview

Metric METHYLENE BLUE METOCLOPRAMIDE
Total FAERS Reports 846 10,911
Deaths Reported 165 1,398
Death Rate 19.5% 12.8%
Hospitalizations 536 3,915
Average Patient Age 48.0 yrs 50.8 yrs
% Female Patients 49.8% 66.5%
FDA Approval Date Apr 8, 2016 Approved Prior to Jan 1, 1982
Manufacturer Zydus Pharmaceuticals USA Inc. Chartwell RX, LLC
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription